Patents by Inventor Dean James
Dean James has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240294512Abstract: Compounds of formula I and pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels are provided. Also provided are pharmaceutical compositions comprising the compounds or pharmaceutically acceptable salts and methods of using the compounds, pharmaceutically acceptable salts, and pharmaceutical compositions in the treatment of various disorders, including pain.Type: ApplicationFiled: June 3, 2022Publication date: September 5, 2024Applicant: VERTEX PHARMACEUTICALS INCORPORATEDInventors: Elizabeth Mary BECK, Robert PULLIN, Gorka ETXEBARRIA JARDI, Dean STAMOS, Yvonne SCHMIDT, Joseph PONTILLO, Stephen Andrew THOMSON, David Matthew SHAW, Nadia M. AHMAD, Lidio Marx CARVALHO MEIRELES, Sarah SKERRATT, Sara S. HADIDA RUAH, Timothy Donald NEUBERT, Dennis James HURLEY, Steven John DURRANT, Christopher WRAY, Anisa Nizarali VIRANI, Kiri NORTH, Bhairavi GALAN, Ronald Marcellus KNEGTEL, Ewa Iwona CHUDYK, Joanne Louise PINDER, Bruno Artur SOUSA, Francoise PIERARD
-
Patent number: 12076324Abstract: The present invention provides, inter alia, methods, kits, and pharmaceutical compositions for treating or ameliorating the effects of a cancer in a subject in need thereof. The method comprises administering to the subject an effective amount of (i) a first anti-cancer agent, which is BVD-523 or a pharmaceutically acceptable salt thereof and (ii) a second anti-cancer agent, which is a CDK inhibitor or a pharmaceutically acceptable salt thereof, to treat or ameliorate the effects of the cancer. Additional methods for effecting cancer cell death are also provided.Type: GrantFiled: May 1, 2023Date of Patent: September 3, 2024Assignee: BIOMED VALLEY DISCOVERIES, INC.Inventors: Saurabh Saha, Dean Welsch, Gary DeCrescenzo, Jeffrey James Roix
-
Patent number: 12057029Abstract: Mobile training labs for training gas technicians are disclosed. The mobile training labs can include a towable trailer comprising a body having a plurality of walls at least partially defining a hollow interior, an axle having at least two wheels disposed thereon to support the body, and a tow hitch. The mobile training labs can also include at least one training bay connected to the towable trailer such that the at least one training bay is configured to be accessed from an exterior of the towable trailer. The at least one training bay can include a work bench and a mock service entrance that is representative of a commercial or residential gas service entrance.Type: GrantFiled: January 11, 2021Date of Patent: August 6, 2024Assignee: QUANTA ASSOCIATES, L.P.Inventors: Mark James Groves, Aaron Howell, Dean Coriell, Phillip Lee Carrillo, Richard Gene Wilson, Ian Chase Richards, Vincent Delmar Kubichek, Philip Bradley-Gil Scarberry, Lawrence M. Krummert
-
Publication number: 20230402885Abstract: Embodiments of the present disclosure are directed to a rotor assembly for use in a radial flux electric motor assembly having core magnets rotatable relative to end magnets such that the torque constant of the rotor assembly varies. The plurality of end magnets is positioned over the core magnets when the rotor assembly is at rest and the rotor assembly has a first torque constant at rest. The plurality of end magnets can rotate relative to the core magnets upon application of torque to the rotor assembly.Type: ApplicationFiled: June 9, 2022Publication date: December 14, 2023Inventors: Mark Thiele, Greg Heins, Dean James Patterson
-
Publication number: 20230190664Abstract: Disclosed are crosslinked particles (e.g., microparticles) that are capable of storing and releasing drugs. The particles can be macroparticles, microparticles, or nanoparticles and can be composed of polyester backbones. The particles can be loaded with a drug. The particles can degrade in vivo to release the drug. The particles can be prepared by crosslinking functionalized polyester backbones and loaded with a given drug. The particles of the present disclosure can be injected with a syringe. In some embodiments, the particles of the present disclosure are administered in connection with a surgery and release the drug after the site of the surgery for a period of 1-6 months.Type: ApplicationFiled: July 22, 2022Publication date: June 22, 2023Inventors: Frantz LE DEVEDEC, Christine ALLEN, David M. STEVENS, Dean James RAGER-AGUIAR, Timothy Tordella RUCKH, Carl Eric ELMQUIST
-
Publication number: 20230052600Abstract: A rotor assembly for use in a radial flux electric motor assembly includes a rotor core having a plurality of rotor poles circumferentially spaced about a central axis, wherein the rotor core includes a first end and an opposing second end. The rotor assembly further includes a plurality of core magnets alternately spaced with the plurality of rotor poles. The plurality of rotor poles define a radial aperture between each pair of circumferentially adjacent rotor poles, and each radial aperture is configured to receive at least one core magnet of the plurality of core magnets therein. A plurality of end magnets are coupled to at least one of the first end and the second end, and at least one end plate coupled to the plurality of end magnets.Type: ApplicationFiled: August 16, 2021Publication date: February 16, 2023Inventors: Mark Thiele, Greg Heins, Dean James Patterson
-
Publication number: 20220357272Abstract: A sensor is disclosed, comprising: a first optical reflector provided on a first support element; a second optical reflector provided on a second support element and arranged opposed to the first optical reflector along an optical axis, the opposed first and second optical reflectors being spaced from each other forming a sample space for containing a sample between the first and second optical reflectors; wherein the second optical reflector comprises a recess to provide an optical cavity with stable resonance in at least one mode and having an optical cavity length of at most 50 ?m and/or an optical mode volume of 100 ?m3 or less; at least one electromagnetic (EM) radiation source configured to illuminate the optical cavity with EM radiation; and a detector configured to detect EM radiation from the optical cavity; wherein the first support element and the second support element are bonded to each other and form a unitary structure.Type: ApplicationFiled: September 15, 2020Publication date: November 10, 2022Inventors: Matteo Contino, Dean James, Robert Andrew Nyman, Jason Michael Smith, Aurélien André Paul Trichet, Claire Vallance
-
Patent number: 11426356Abstract: Disclosed are crosslinked particles (e.g., microparticles) that are capable of storing and releasing drugs. The particles can be macroparticles, microparticles, or nanoparticles and can be composed of polyester backbones. The particles can be loaded with a drug. The particles can degrade in vivo to release the drug. The particles can be prepared by crosslinking functionalized polyester backbones and loaded with a given drug. The particles of the present disclosure can be injected with a syringe. In some embodiments, the particles of the present disclosure are administered in connection with a surgery and release the drug after the site of the surgery for a period of 1-6 months.Type: GrantFiled: February 27, 2019Date of Patent: August 30, 2022Assignees: Pendant Biosciences, Inc., The Governing Council of the University of TorontoInventors: Frantz Le Devedec, Christine Allen, David M. Stevens, Dean James Rager-Aguiar, Timothy Tordella Ruckh, Carl Eric Elmquist
-
Patent number: 11235030Abstract: Provided herein are compositions and methods for the treatment of tendinopathies, such as tenosynovitis, tendinosis or tendinitis, including Achilles tendinopathy, patellar tendinopathy, lateral epicondylitis or “tennis elbow,” medial epicondylitis or “golfer's elbow,” plantar fasciitis, and rotator cuff tendinopathy, and in particular to methods for the treatment of tendinopathies by administering compositions comprising platelet-derived growth factor (PDGF).Type: GrantFiled: October 15, 2019Date of Patent: February 1, 2022Assignee: BioMimetic Therapeutics, LLCInventors: Hans K. Kestler, Vivek Shah, Dean James Rager-Aguiar
-
Patent number: 10770940Abstract: A rotor module for an axial flux electric machine includes a back iron segment configured for attachment to a rotor base and a plurality of permanent magnets attached to the back iron segment. The back iron segment has a length less than a circumference of the rotor base. Each permanent magnet attached to the back iron segment has an opposite magnetic pole orientation from each adjacent permanent magnet attached to the back iron segment. A plurality of rotor modules is coupled to the rotor base to form a rotor for the axial flux electric machine.Type: GrantFiled: January 31, 2017Date of Patent: September 8, 2020Assignee: Regal Beloit Australia Pty Ltd.Inventors: Mark Thiele, Greg Heins, Matthew J. Turner, Dean James Patterson
-
Publication number: 20200222504Abstract: Provided herein are compositions and methods for the treatment of tendinopathies, such as tenosynovitis, tendinosis or tendinitis, including Achilles tendinopathy, patellar tendinopathy, lateral epicondylitis or “tennis elbow,” medial epicondylitis or “golfer's elbow,” plantar fasciitis, and rotator cuff tendinopathy, and in particular to methods for the treatment of tendinopathies by administering compositions comprising platelet-derived growth factor (PDGF).Type: ApplicationFiled: October 15, 2019Publication date: July 16, 2020Inventors: Hans K. Kestler, Vivek Shah, Dean James Rager-Aguiar
-
Patent number: 10594180Abstract: A rotor for an electric machine includes a circular rotor base having a first surface, a second surface, and a circumferential outer edge extending from the first surface to the second surface, a plurality of magnets disposed proximate the circumferential outer edge of the circular rotor base, and a plurality of flux guides. Each magnet has a first surface and a second surface. The first surface of each magnet is attached to the first surface of the circular rotor base, and the second surface of each magnet defines a first shape. Each flux guide is attached to the second surface of a different magnet and has a first surface attached to the second surface of a first respective magnet and a second surface opposite the first surface. The second surface of each flux guide defines a second shape different than the first shape of the magnets.Type: GrantFiled: January 31, 2017Date of Patent: March 17, 2020Assignee: Regal Beloit America, Inc.Inventors: Greg Heins, Mark Thiele, Dean James Patterson, Matthew J. Turner
-
Patent number: 10541591Abstract: A stator for an axial flux machine includes a back iron, a plurality of stator teeth extending from the back iron, and a plurality of tooth tips attached to the stator teeth. The back iron and the stator teeth include a first material. Each stator tooth has a first end proximate the back iron and a second end. Each tooth tip is attached to the second end of a different stator tooth. The tooth tips include a second material different than the first material.Type: GrantFiled: January 31, 2017Date of Patent: January 21, 2020Assignee: REGAL BELOIT AUSTRALIA PTY, LTD.Inventors: Dean James Patterson, Mark Thiele, Greg Heins, Matthew J. Turner
-
Patent number: 10512888Abstract: Systems and methods provide automated parameter assurance features and results for consumables used in bioprocessing and particularly for purifying, filtering, harvesting and collecting bioprocessing fluids. Consumables having these features are sized, shaped, configured and constructed to interface with and be a component of such a bioprocessing system that includes a multi-use component or device with which it operatively engages such as by docking, engagement with a connector or other approach that allows for insertion and removal of the consumable. The consumable may be a component having a single-use life or a limited life. Each consumable has a median by which information, which can include use limits and specifications, is associated with that specific consumable, and those limits and specifications are communicated to the multi-use component which indicates any inappropriateness for use with the multi-use component.Type: GrantFiled: June 23, 2015Date of Patent: December 24, 2019Assignee: Parker-Hannifin CorporationInventors: Dean James Pighin, Richard Krmit Bergs, Donald Robert Beers, Peter Anthony D'Antonio, Jr.
-
Patent number: 10493130Abstract: Provided herein are compositions and methods for the treatment of tendinopathies, such as tenosynovitis, tendinosis or tendinitis, including Achilles tendinopathy, patellar tendinopathy, lateral epicondylitis or “tennis elbow,” medial epicondylitis or “golfer's elbow,” plantar fasciitis, and rotator cuff tendinopathy, and in particular to methods for the treatment of tendinopathies by administering compositions comprising platelet-derived growth factor (PDGF).Type: GrantFiled: March 31, 2017Date of Patent: December 3, 2019Assignee: BIOMIMETIC THERAPEUTICS, LLCInventors: Hans K. Kestler, Vivek Shah, Dean James Rager-Aguiar
-
Patent number: 10447102Abstract: An electric machine comprising a permanent magnet rotor assembly is provided. The electric machine comprises a permanent magnet rotor assembly comprising a plurality of permanent magnets coupled to a rotor disk and a plurality of magnet shims coupled to the plurality of permanent magnets opposite the rotor disk. Each magnet shim of the plurality of magnet shims has a substantially complementary shape as a respective permanent magnet of the plurality of permanent magnets. The electric machine further comprises a stator core comprising a plurality of stator teeth that define a plurality of slots therebetween. At least one of the plurality of magnet shims is configured to direct magnetic flux from at least one of the plurality of permanent magnets to at least one stator tooth of the plurality of stator teeth.Type: GrantFiled: March 15, 2013Date of Patent: October 15, 2019Assignee: Regal Beloit Australia Pty. Ltd.Inventors: Dean James Patterson, Rafal Pawel Rohoza, Steven Peter Camilleri, Matthew Turner, Charles Richard Langford
-
Publication number: 20190262274Abstract: Disclosed are crosslinked particles (e.g., microparticles) that are capable of storing and releasing drugs. The particles can be macroparticles, microparticles, or nanoparticles and can be composed of polyester backbones. The particles can be loaded with a drug. The particles can degrade in vivo to release the drug. The particles can be prepared by crosslinking functionalized polyester backbones and loaded with a given drug. The particles of the present disclosure can be injected with a syringe. In some embodiments, the particles of the present disclosure are administered in connection with a surgery and release the drug after the site of the surgery for a period of 1-6 months.Type: ApplicationFiled: February 27, 2019Publication date: August 29, 2019Inventors: Frantz Le Devedec, Christine Allen, David M. Stevens, Dean James Rager-Aguiar, Timothy Tordella Ruckh, Carl Eric Elmquist
-
Patent number: 10258578Abstract: Disclosed are crosslinked particles (e.g., microparticles) that are capable of storing and releasing drugs. The particles can be macroparticles, microparticles, or nanoparticles and can be composed of polyester backbones. The particles can be loaded with a drug. The particles can degrade in vivo to release the drug. The particles can be prepared by crosslinking functionalized polyester backbones and loaded with a given drug. The particles of the present disclosure can be injected with a syringe. In some embodiments, the particles of the present disclosure are administered in connection with a surgery and release the drug after the site of the surgery for a period of 1-6 months.Type: GrantFiled: October 7, 2016Date of Patent: April 16, 2019Assignee: PENDANT BIOSCIENCES, INC.Inventors: Frantz Le Dévédec, Christine Jane Allen, David M. Stevens, Dean James Rager-Aguiar, Timothy Tordella Ruckh, Carl Eric Elmquist
-
Patent number: D1038762Type: GrantFiled: October 7, 2021Date of Patent: August 13, 2024Assignee: DEB IP LIMITEDInventors: Christopher James Lang, Dean Philip Limbert, Robert Butler
-
Patent number: D1038763Type: GrantFiled: October 7, 2021Date of Patent: August 13, 2024Assignee: DEB IP LIMITEDInventors: Christopher James Lang, Dean Philip Limbert, Robert Butler